03/19/2026
The Joe Tippens Case: Challenging the Statistics 🛡️
In 2016, Joe Tippens was given 3 months to live. Today, his story is one of the most powerful examples of how metabolic oncology can change the rules of the game.
Here is why this case is analyzed by leading experts like Dr. Paul Marik and Dr. William Makis:
1️⃣ Metabolic Targeting: Fenbendazole (a repurposed drug) has been shown to block glucose uptake in cancer cells. Without its primary fuel source, the malignant cell loses its ability to survive.
2️⃣ The Mitosis Killer: It acts as a tubulin inhibitor—disrupting the "skeleton" of the cancer cell, which prevents it from dividing (mitosis). If the cell cannot divide, it undergoes programmed death (apoptosis).
3️⃣ Synergistic Protocol: Joe combined Fenbendazole with Vitamin E, Curcumin, and CBD. This multi-targeted approach blocks the survival pathways that standard treatments often miss.
The Joe Tippens case is proof that statistics are not a death sentence.
